Concurrent overexpression of RET/PTC1 and TTF1 confers tumorigenicity to thyrocytes.

about

Adipogenic Differentiation of Thyroid Cancer Cells Through the Pax8-PPARγ Fusion Protein Is Regulated by Thyroid Transcription Factor 1 (TTF-1).Consensus reference gene(s) for gene expression studies in human cancers: end of the tunnel visible?

P2860

Q38756909-AD92F46B-8EBA-4536-93E4-F8DED2B29D44 Q53527300-3EDBA873-9C97-4486-8716-D6CDEE3C133D

P2860

Concurrent overexpression of RET/PTC1 and TTF1 confers tumorigenicity to thyrocytes.

Item

http://www.wikidata.org/entity/Q41822268

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Concurrent overexpression of RET/PTC1 and TTF1 confers tumorigenicity to thyrocytes.

@en

type

Item

label

Concurrent overexpression of RET/PTC1 and TTF1 confers tumorigenicity to thyrocytes.

@en

prefLabel

Concurrent overexpression of RET/PTC1 and TTF1 confers tumorigenicity to thyrocytes.

@en

P1476

Concurrent overexpression of RET/PTC1 and TTF1 confers tumorigenicity to thyrocytes.

@en

P2093

Tetsuro Kobayashi

http://www.w3.org/2001/XMLSchema#string

Toyoshi Endo

http://www.w3.org/2001/XMLSchema#string

P2860

Thyroid transcription factor in differentiating type II cells: regulation, isoforms, and target genes

The RET/PTC-RAS-BRAF linear signaling cascade mediates the motile and mitogenic phenotype of thyroid cancer cells

Correlation between B-RAFV600E mutation and clinico-pathologic parameters in papillary thyroid carcinoma: data from a multicentric Italian study and review of the literature.

In vivo role of different domains and of phosphorylation in the transcription factor Nkx2-1.

BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer.

The thyrotropin receptor hinge region is not simply a scaffold for the leucine-rich domain but contributes to ligand binding and signal transduction.

Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations

Thyroid transcription factor-1 activates the promoter activity of rat thyroid Na+/I- symporter gene.

Mouse models for BRAF-induced cancers

Molecular genetics and diagnosis of thyroid cancer.

P304

767-776

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1530/ERC-13-0310

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-10-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24014739

http://www.w3.org/2001/XMLSchema#string

P921

overexpression

P932

3796879

http://www.w3.org/2001/XMLSchema#string

Concurrent overexpression of RET/PTC1 and TTF1 confers tumorigenicity to thyrocytes.

about

P2860

P2860

Concurrent overexpression of RET/PTC1 and TTF1 confers tumorigenicity to thyrocytes.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932